Articles From: Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin to ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma


Shares of General Mills (GIS) fell 3.2% in premarket trade after the packaged food maker reported fiscal first-quarter profit and sales that fell more than expected.
Sign-up for General Mills shares fall after disappointing quarterly profit, sales investment picks
VANCOUVER, British Columbia, Sept.
Sign-up for QLT Provides Update on Merger With Auxilium Pharmaceuticals, Inc. investment picks
Patents granted by the United States Patent and Trademark Office and European Patent Office and a notice of allowance from the Japanese Patent Office broaden the breadth of the Company's delivery technology platform MARLBOROUGH, Mass.
Sign-up for RXi Pharmaceuticals Strengthens Intellectual Property Portfolio investment picks
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced that its Chairman and CEO, Jonathan Lim, M.D., has been invited to participate in upcoming panel discussions relating to innovation in Rx/Dx strategies and novel science developments in precision medicine.
Sign-up for Ignyta to Participate in Precision Medicine Panel Discussions with Other Thought Leaders investment picks
http://media.marketwire.com/attachments/201311/207012_jpg_IPC_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144827&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Ideal Power Receives Multi-Unit Orders From Sharp investment picks
http://media.marketwire.com/attachments/201211/102974_EvolvinglogoR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145205&ProfileId=051205&sourceType=1 ENGLEWOOD, CO --
Sign-up for African Operator Improves SIM Logistics and Enhances the Customer Experience With Major Upgrade to Evolving Systems' Dynamic SIM Allocation(TM) Solution investment picks
Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J. , Sept.
Sign-up for Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma investment picks
Glitz, glamour and red-carpet service arrive in Northeast Ohio today as Penn National Gaming (Nasdaq: PENN) invites the public to step inside the $250 million state-of-the-art Hollywood Gaming at Mahoning Valley Race Course (“Hollywood Gaming”) for the very first time.
Sign-up for Hollywood Gaming at Mahoning Valley Race Course Rolls out the Red Carpet investment picks
Adopts One Year Stockholder Rights Plan CHESTERBROOK, Pa.
Sign-up for Auxilium Responds To Unsolicited Proposal From Endo International investment picks
Signature Bank (Nasdaq: SBNY), a New York-based full-service commercial bank, announced today that it was named Best Business Bank by the New York Law Journal in the publication’s fifth annual reader survey .
Sign-up for Signature Bank Named Best Business Bank by New York Law Journal in Annual Reader Survey investment picks
Actuate Corporation (NASDAQ:BIRT), The BIRT Company™ and the leader in personalized analytics and insights, today announced its participation in an upcoming TDWI webinar called, “Making Data Beautiful for Business Users: Tips for Creating Rich, Visual and Actionable User Experiences.” Allen Bonde ( @abonde ), Actuate’s VP of Product Marketing and Innovation, and David Stodder ( @dbstodder ), TDWI’s Research Director for Business Intelligence, will share best practices and current technology trends.
Sign-up for Actuate's Allen Bonde and TDWI’s David Stodder to Discuss Creating Rich User Experiences in Complimentary Webinar on September 23 investment picks
Key Takeaways: Comverse will demonstrate thought leadership at PT/EXPO COMM CHINA in Beijing September 23-27, 2014 In a key presentation/demo addressing industry trends, Comverse will unveil innovative solutions engineered to boost CSP relevance and profitability in today's increasingly digital communications environment WAKEFIELD, Mass., Sept.
Sign-up for Comverse Unveils Digital Lifestyle Solutions at PT/EXPO COMM CHINA investment picks
Independent, 3rd party scientists review psoriasis treatments and the benefits of small molecule drugs including CF101; The psoriasis therapeutic market was worth $3.6 billion in 2010 and is forecast to grow to $6.7 billion by 2018, according to Global Data PETACH TIKVA, Israel , Sept.
Sign-up for Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of Psoriasis investment picks
http://media.marketwire.com/attachments/200710/373693_AAONLogoPMS300.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144992&ProfileId=051205&sourceType=1 TULSA, OK --
Sign-up for AAON, Inc. to Donate $3 Million to A Gathering Place for Tulsa investment picks
RetailMeNot Offers Retailers and Brands an Efficient Alternative to Old-School Print Promotions With Launch of New Digital Retailer Solutions AUSTIN, Texas , Sept.
Sign-up for Introducing What's Next in Retail Marketing: The RetailMeNot Circular and RetailMeNot Showcase™ investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated a Phase 1 clinical trial of CTP-730 , a novel product candidate that is being developed under its strategic collaboration with Celgene Corporation .
Sign-up for Concert Pharmaceuticals Announces Initiation of CTP-730 Phase 1 Clinical Trial Under Celgene Collaboration investment picks
Redknee Signs $8 Million Dollars of Orders with Operator in the Americas Canada NewsWire TORONTO , Sept.
Sign-up for Redknee Signs $8 Million Dollars of Orders with Operator in the Americas investment picks
TORONTO, Sept.
Sign-up for NOVADAQ to Host Analyst & Investor Day on November 17, 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G021986-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/17/11G021986/MBAC_Fertilizer_Corp.-882423241346.jpg TORONTO, ON--(Marketwired - September 17, 2014) - MBAC Fertilizer Corp.
Sign-up for MBAC Fertilizer Reaches Record Daily SSP Production at Its Itafós Operations investment picks
HOUSTON, Sept.
Sign-up for ENGlobal Finalizes Credit Facility With Regions Bank investment picks
GLASTONBURY, Conn., Sept.
Sign-up for United Financial Bancorp, Inc. Announces Commencement of Subordinated Notes Offering investment picks
http://media.marketwire.com/attachments/201409/TN-276784_CiscoIoEInnovationCenter_1.jpg Fog computing in action http://media.marketwire.com/attachments/201409/TN-276785_CiscoIoEInnovationCenter_2.jpg Rapid solution prototype for Remote site management http://media.marketwire.com/attachments/201112/37284_CISCO_small-business.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145106&ProfileId=051205&sourceType=1 BERLIN, GERMANY --
Sign-up for Cisco Brings Internet of Everything (IoE) Innovation Center to Berlin investment picks
The addition of leading UK live-events AV provider grows GES' client offerings across the UK, Europe and the Middle East LAS VEGAS , Sept.
Sign-up for GES Expands Audio Visual Services with Acquisition of UK-based Blitz Communications investment picks
Expands GES' Audio-Visual Services Offering with Acquisition of UK-based Blitz Communications PHOENIX , Sept.
Sign-up for Viad Corp Acquires Audio-Visual Services Firm investment picks
http://media.marketwire.com/attachments/200501/200497_SciCloneLogo-Color-R.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145120&ProfileId=051205&sourceType=1 FOSTER CITY, CA --
Sign-up for SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014 investment picks
AVEO Oncology (NASDAQ:AVEO) today announced that clinical data on ficlatuzumab, the Company’s hepatocyte growth factor (HGF) inhibitory antibody, as well as tivozanib, the Company’s inhibitor of vascular endothelial growth factor (VEGF) 1, 2, and 3 receptors, will be presented at the European Society of Medical Oncology (ESMO) 2014 Congress in Madrid, Spain, September 26 – September 30, 2014.
Sign-up for Clinical Data on AVEO Oncology’s Ficlatuzumab and Tivozanib to Be Presented at the ESMO 2014 Congress investment picks
ICT-107 Phase II Update Selected for Oral Presentation at Society for Neuro-Oncology Meeting in November; ICT-121 and ICT-140 Programs on Track LOS ANGELES , Sept.
Sign-up for ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin to ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices